ELI LILLY & Co 4

Director Juan R. Luciano received a small stock-based compensation award of Eli Lilly & Co common stock units in lieu of cash, increasing his holdings to 16,918.0448 shares.

On August 17, 2026, director Juan R. Luciano acquired 13.4527 shares of Eli Lilly & Co common stock, valued at approximately $1,183.16, not through an open-market purchase but via the Lilly Directors' Deferral Plan, in which he elected to defer cash compensation into stock units that will be settled in common shares upon his separation from service. Following this award, his total deferred and directly held common stock equivalent ownership increased to 16,918.0448 shares, representing an estimated position of about $20.7 million based on the current market price. The transaction is a routine form of director compensation rather than a discretionary purchase or sale in the open market.

Filing Facts

CIK

59478

Ticker

LLY

Form

4

Source Type

fda

Accession

0000059478-26-000087

Alert Tier

5